Ducking the crossfire of cross-resistance (Glasgow. Part 1).
Mascolini
M
M
mailmark@ptd.net
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000235:genetics; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D017720:Molecular Epidemiology; D009154:Mutation / Q000235:genetics; D010641:Phenotype; D016879:Salvage Therapy / Q000379:methods; D017211:Treatment Failure
D019380:Anti-HIV Agents; D004279:DNA, Viral